Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-16

Clinical Trial Update: The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids on p38 MAPK in Asthma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating whether adding simvastatin to inhaled corticosteroids provides additional anti-inflammatory effects on p38 MAPK in asth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Mahidol University | Conditions: Asthma | Phase 3 | Status: COMPLETED